U.S. federal trademark · Serial No. 98957032
Clinical research and scientific studies in the field of the efficacy and benefits of accelerated mental health treatment protocols, including collaboration with academic and medical institutions for the further development of accelerated transcranial magnetic stimulation protocols
Marketing services, branding services, namely, brand development services and business consulting services for licensed providers offering transcranial magnetic stimulation protocols; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of accelerated transcranial magnetic stimulation protocols
Educational services, namely, conducting training programs for clinicians in the use of transcranial magnetic stimulation technology and protocols; providing training of clinicians for certification in the field of transcranial magnetic stimulation technology and protocols; educational services, namely, conducting workshops in the field of mental health and cognitive wellness and distribution of educational materials in connection therewith
Licensing of intellectual property in the field of treatment protocols for healthcare providers
Mental health services; medical services, namely, transcranial magnetic stimulation; medical treatment of neuro-psychiatric diseases; medical treatment of major depressive disorder and anxious depression with transcranial magnetic stimulation therapy; medical services, namely, the use of transcranial magnetic stimulation to treat major depressive disorder, anxious depression, and obsessive-compulsive disorder; cognitive wellness services, namely, mental health services and behavioral health services; medical services, namely, implementing medical protocols for mental health and neurological treatments, including accelerated transcranial magnetic stimulation (TMS) protocols; medical services, namely, implementing accelerated mental health treatment protocols; psychiatric services, namely, providing psychiatric therapies for treatment-resistant depression, providing transcranial magnetic stimulation therapies, administering ketamine therapies, administering nasal spray medication taken with an oral antidepressant, and providing mental health counseling; telemedicine services, namely, providing consultations and support for patients undergoing accelerated mental health treatment protocols
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.